Sign in

CIK 0001281895

  • Non-accelerated filer
  • Smaller reporting company

ROCKET PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-440-9100
Business address
350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
Former names
INOTEK PHARMACEUTICALS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$395,614
in 3 filings

Net −$395,614. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Wilson Martin −$384K General Counsel sold 19% of stake
  2. Chaudhuri Sarbani −$11K See Remarks sold 2% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-05-14 Wilson Martin General Counsel Option exercise · Restricted Stock Units −2,420 16,947
2024-05-14 Patel Kinnari See Remarks Option exercise +3,990 296,291
2024-05-14 Patel Kinnari See Remarks Option exercise +5,553 301,824
2024-05-14 Patel Kinnari See Remarks Option exercise · Restricted Stock Units −3,990 11,970
2024-05-14 Patel Kinnari See Remarks Option exercise · Restricted Stock Units −5,533 38,735
2024-05-02 SOUTHWELL DAVID P Director Gift −113,124 1,660
2024-05-02 SOUTHWELL DAVID P Director Gift −59,716 113,124
2024-04-22 Militello John See Remarks Sale −833 $22.87 $19K 54,406
2024-04-15 SOUTHWELL DAVID P Director Option exercise +29,624 $4.34 $129K 124,784
2024-04-15 SOUTHWELL DAVID P Director Sale −10,000 $24.05 $241K 114,784
2024-04-15 SOUTHWELL DAVID P Director Option exercise · Stock Option (Right to Buy) −29,624 $4.34 $129K 0
2024-04-12 SOUTHWELL DAVID P Director Option exercise +70,000 $4.34 $304K 165,160
2024-04-12 SOUTHWELL DAVID P Director Sale −59,716 $24.22 $1.4M 105,444
2024-04-12 SOUTHWELL DAVID P Director Sale −10,284 $25.16 $259K 95,160
2024-04-12 SOUTHWELL DAVID P Director Option exercise · Stock Option (Right to Buy) −70,000 $4.34 $304K 29,624
2024-04-08 White Mark Andrew See Remarks Sale −12,532 $24.64 $309K 75,226
2024-04-01 Ondrey Aaron Chief Financial Officer Grant or award +46,781 46,781
2024-04-01 Ondrey Aaron Chief Financial Officer Grant or award · Stock Option (Right to Buy) +69,337 69,337
2024-03-21 Makker Gotham Director Sale −274,000 $28.43 $7.8M 365,912
2024-03-21 Makker Gotham Director Sale −274,000 $28.43 $7.8M 365,912

Page 11 of 19 · 374 trades